Andrea Janíková

Positron Emission Tomography–Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants

Judith Trotman, Marion Fournier, T. Lamy et al. · Journal of Clinical Oncology · 2011 · 216 citations · Full text

Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study

Antonio Salar, Irit Avivi, Beate Bittner et al. · Journal of Clinical Oncology · 2014 · 92 citations · Full text

Phase Ib Study, Iv Rituximab, Lymphoid Neoplasia +14

miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels

Kateřina Musilová, Ján Deván, Kateřina Amruz Černá et al. · Blood · 2018 · 72 citations · Full text

Value of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Follicular Lymphoma: The End of a Dilemma?

Andrea Janíková, Karol Bolčák, Tomáš Pavlík et al. · Clinical Lymphoma & Myeloma · 2008 · 66 citations

Positron Emission Tomography, Lymphoid Neoplasia, Medical Imaging +5

A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

Marek Trněný, Gregor Verhoef, Martin J.S. Dyer et al. · Haematologica · 2018 · 60 citations · Full text